Literature DB >> 1967688

Two distinct forms of vancomycin resistance amongst enterococci in the UK.

N Woodford, A P Johnson, D Morrison, A T Chin, J R Stephenson, R C George.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967688     DOI: 10.1016/0140-6736(90)90317-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Screening for vancomycin-resistant enterococci: an efficient and economical laboratory-developed test.

Authors:  H Fang; A-K Ohlsson; G-X Jiang; M Ullberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-10       Impact factor: 3.267

Review 2.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas.

Authors:  F J Caballero-Granado; J M Cisneros; R Luque; M Torres-Tortosa; F Gamboa; F Díez; J L Villanueva; R Pérez-Cano; J Pasquau; D Merino; A Menchero; D Mora; M A López-Ruz; A Vergara
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Selective medium for screening for vancomycin-resistant enterococci in faeces.

Authors:  G G Rao; K Ghanekar; F Ojo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

Review 5.  Resistance to vancomycin and teicoplanin: an emerging clinical problem.

Authors:  A P Johnson; A H Uttley; N Woodford; R C George
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

Review 6.  Anti-infective treatment in intensive care: the role of glycopeptides.

Authors:  R N Grüneberg; A P Wilson
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

7.  vanA gene cluster in a vancomycin-resistant clinical isolate of Bacillus circulans.

Authors:  M Ligozzi; G Lo Cascio; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

8.  Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic.

Authors:  B P Goldstein; G Candiani; T M Arain; G Romanò; I Ciciliato; M Berti; M Abbondi; R Scotti; M Mainini; F Ripamonti
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.